Literature DB >> 12457910

Suppression of experimental autoimmune uveoretinitis by anti-alphabeta TCR monoclonal antibody.

Taeko Inoki1, Satoru Yamagami, Rieko Sakai, Mitsuaki Isobe, Tadahiko Tsuru, Hidetoshi Kawashima.   

Abstract

PURPOSE: To evaluate the effects of anti-alphabeta T cell receptor monoclonal antibody (R73) on the induction of experimental autoimmune uveoretinitis (EAU) in rats.
METHODS: Lewis rats in which EAU was induced were treated with R73. All rats were examined for the clinical course of EAU, pathological findings of the globe, delayed-type hypersensitivity, and the interleukin-2 (IL-2) gene and protein expression in the eye.
RESULTS: The R73 treatment was effective for delaying EAU onset, decreasing the severity of EAU, and suppressing delayed-type hypersensitivity to the antigen. IL-2 gene and protein expression was reduced by R73 treatment in the anterior and posterior segments of the eye.
CONCLUSION: R73 treatment is effective for suppression of the development of EAU, inhibiting IL-2 expression in the eye.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12457910     DOI: 10.1016/s0021-5155(02)00538-5

Source DB:  PubMed          Journal:  Jpn J Ophthalmol        ISSN: 0021-5155            Impact factor:   2.447


  4 in total

Review 1.  Emerging role of antioxidants in the protection of uveitis complications.

Authors:  U C S Yadav; N M Kalariya; K V Ramana
Journal:  Curr Med Chem       Date:  2011       Impact factor: 4.530

2.  Down-regulation of inducible co-stimulator (ICOS) by intravitreal injection of small interfering RNA (siRNA) plasmid suppresses ongoing experimental autoimmune uveoretinitis in rats.

Authors:  Yongsheng Hou; Lin Xing; Shaoying Fu; Xiaoning Zhang; Jingjing Liu; Hongling Liu; Bingjie Lv; Hao Cui
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2009-01-06       Impact factor: 3.117

3.  Efficacy of Sub-Tenon Micro-Perfusion of Cyclophosphamide in Rabbits with Severe Ocular Inflammation.

Authors:  Libei Zhao; Manqiang Peng; Wenxiang Lin; Qian Tan; Muhammad Ahmad Khan; Ding Lin
Journal:  Drug Des Devel Ther       Date:  2020-08-20       Impact factor: 4.162

4.  Treatment of experimental autoimmune uveoretinitis with peroxisome proliferator-activated receptor α agonist fenofibrate.

Authors:  Miho Osada; Tsutomu Sakai; Kana Kuroyanagi; Hideo Kohno; Hiroshi Tsuneoka
Journal:  Mol Vis       Date:  2014-11-04       Impact factor: 2.367

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.